(Institución)/></a>
				</td>
				<td class= (Institución)
   (Nuevo usuario)
Ayuda  | Contacto  |  Castellano English  
 

Dadun > Depósito Académico > CIMA (Centro de Investigación Médica Aplicada) > Área de Terapia génica y Hepatología > Inmunología hepatitis virales > DA - CIMA - Terapia génica y Hepatología - Inmunología hepatitis virales - Artículos de revista >

Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity
Autor(es) : Rollier, C.S. (Christine S.)
Paranhos-Baccala, G. (Glaucia)
Verschoor, E.J. (Ernst J.)
Verstrepen, B.E. (Babs E.)
Drexhage, J.A.R. (Joost A.R.)
Fagrouch, Z. (Zahra)
Berland, J.L. (Jean-Luc)
Komurian-Pradel, F. (Florence)
Duverger, B. (Blandine)
Himoudi, N. (Nourredine)
Staib, C. (Caroline)
Meyr, M. (Marcus)
Whelan, M. (Myke)
Whelan, J.A. (Joseph A.)
Adams, V.A. (Victoria A.)
Larrea, E. (Esther)
Riezu-Boj, J.I. (José Ignacio)
Lasarte, J.J. (Juan José)
Bartosch, B. (Birke)
Cosset, F. L. (Francoise-L.)
Spaan, W.J.M. (Willy J.M.)
Diepolder, H.M. (Helmut M.)
Pape, G.R. (Gerd R.)
Sutter, G. (Gerd)
Inchauspe, G. (Geneviese)
Heeney, J.L. (Jonathan L.)
Palabras clave : Antigens, CD/metabolism
Hepatitis C/immunology
Viral Hepatitis Vaccines/therapeutic use
Fecha incorporación: 2007
Editorial : Wiley-Blackwell
Versión del editor: http://onlinelibrary.wiley.com/doi/10.1002/hep.21573/abstract
ISSN: 1527-3350
Cita: Rollier CS, Paranhos-Baccala G, Verschoor EJ, Verstrepen BE, Drexhage JA, Fagrouch Z, et al. Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity. Hepatology 2007 Mar;45(3):602-613.
Resumen
Broad T cell and B cell responses to multiple HCV antigens are observed early in individuals who control or clear HCV infection. The prevailing hypothesis has been that similar immune responses induced by prophylactic immunization would reduce acute virus replication and protect exposed individuals from chronic infection. Here, we demonstrate that immunization of naïve chimpanzees with a multicomponent HCV vaccine induced robust HCV-specific immune responses, and that all vaccinees exposed to heterologous chimpanzee-adapted HCV 1b J4 significantly reduced viral RNA in serum by 84%, and in liver by 99% as compared to controls (P=0.024 and 0.028, respectively). However, despite control of HCV in plasma and liver in the acute period, in the chronic phase, 3 of 4 vaccinated animals developed persistent infection. Analysis of expression levels of proinflammatory cytokines in serial hepatic biopsies failed to reveal an association with vaccine outcome. However, expression of IDO, CTLA-4 [corrected] and PD-1 levels in liver correlated with clearance or chronicity. CONCLUSION: Despite early control of virus load, a virus-associated tolerogenic-like state can develop in certain individuals independent of vaccination history.
Enlace permanente: http://hdl.handle.net/10171/21727
Aparece en las colecciones: DA - CIMA - Terapia génica y Hepatología - Inmunología clínica - Artículos de revista
DA - CUN - Medicina interna - Artículos de revista
DA - CIMA - Terapia génica y Hepatología - Virología - Artículos de revista
DA - Medicina - Medicina Interna - Artículos de revista
DA - CIMA - Terapia génica y Hepatología - Inmunología hepatitis virales - Artículos de revista

Ficheros en este registro:

No hay ficheros asociados a este ítem.

Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.